These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings]. Bianchetti G; Gomeni R; Kilborn JR; Morselli PL; Taylor EA; Warrington SJ Br J Clin Pharmacol; 1979 Oct; 8(4):403P-404P. PubMed ID: 41556 [No Abstract] [Full Text] [Related]
7. Beta-adrenoceptor blocking drugs at maximum beta-blockade in relation to dose and plasma concentration. Gugler R; Krist R; Raczinski H; Höffgen K; Boden G Cardiology; 1979; 64 Suppl 1():20-4. PubMed ID: 42486 [No Abstract] [Full Text] [Related]
8. Duration of action and plasma levels of beta-adrenoceptor blocking drugs. Aellig WH Arch Int Pharmacodyn Ther; 1980; Suppl():32-7. PubMed ID: 6106456 [TBL] [Abstract][Full Text] [Related]
9. Pravastatin reverses the down-regulating effect of inflammation on beta-adrenergic receptors: a disease-drug interaction between inflammation, pravastatin, and propranolol. Clements JD; Jamali F Vascul Pharmacol; 2007 Jan; 46(1):52-9. PubMed ID: 16949884 [TBL] [Abstract][Full Text] [Related]
10. The effects of beta-adrenoceptor antagonists on proinflammatory cytokine concentrations after subarachnoid hemorrhage in rats. Kato H; Kawaguchi M; Inoue S; Hirai K; Furuya H Anesth Analg; 2009 Jan; 108(1):288-95. PubMed ID: 19095864 [TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacodynamics and plasma levels of beta-adrenoceptor blocking drugs. Gugler R; Krist R; Raczinski H; Höffgen K; Bodem G Br J Clin Pharmacol; 1980 Oct; 10(4):337-43. PubMed ID: 6108780 [TBL] [Abstract][Full Text] [Related]
12. Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists? Jack DB Br J Clin Pharmacol; 1981 Apr; 11(4):402-6. PubMed ID: 6114740 [No Abstract] [Full Text] [Related]
13. An assessment of beta-adrenoceptor blockade in man by SK & F 92657, a new drug with combined vasodilator and beta-adrenoceptor blocking actions, and comparison with propranolol [proceedings]. Pitcher DW; Curry PV; Trounce JR Br J Clin Pharmacol; 1980 Mar; 9(3):300P-301P. PubMed ID: 6102474 [No Abstract] [Full Text] [Related]
14. The assessment of beta-adrenoceptor blocking drugs in man. McDevitt DG Br J Clin Pharmacol; 1977 Aug; 4(4):413-25. PubMed ID: 20123 [No Abstract] [Full Text] [Related]
15. Relationship between plasma beta-adrenoceptor blocker concentration and pharmacodynamic activity. Silke B Br J Clin Pharmacol; 1982 Feb; 13(2):256-7. PubMed ID: 6120714 [No Abstract] [Full Text] [Related]
16. A further study on antihypertensive action of beta-adrenoceptor blocking agents in conscious, renal hypertensive dogs. Himori N; Ishimori T; Taira N Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):115-27. PubMed ID: 44454 [TBL] [Abstract][Full Text] [Related]